Case report: Treatment of two cases of recurrent/refractory early T-cell precursor acute lymphoblastic leukemia with venetoclax combined with the CAG regimen
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a highly aggressive subtype of T-ALL. No standard chemotherapy regimen exists for patients with recurrent/refractory (R/R) ETP-ALL; in these patients, the primary goal of salvage therapy is to achieve remission as a foundation for cons...
Autores principales: | , , , , , , , |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2024-03-01
|
Colección: | Frontiers in Medicine |
Materias: | |
Acceso en línea: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1358161/full |